In a notable performance, Becton Dickinson and Co. (NYSE:BDX) stock achieved a 52-week high, reaching a price level of ...
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price ...
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology firm with a market capitalization of $72.47 billion, declared a quarterly dividend and the ...
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science ...
Atomi Financial Group Inc. lifted its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 25.3% in the ...
Becton Dickinson and Co (BDX) stock saw a decline, ending the day at $232.59 which represents a decrease of $-3.21 or -1.36% from the prior close of $235.8. The stock opened at $237 and touched a low ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Becton, Dickinson and Company (NYSE:BDX), a leading player in the medical technology sector with a market capitalization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback